Showing results (1-10 of 257) with videos related to
Sort By:
Pageof 26
Life Sciences|October 6, 2005
The most widely recognized mushroom: chemistry of the genus AmanitaChen Li, Nicholas H OberliesNatural Product Reports|July 14, 2023
From plant to cancer drug: lessons learned from the discovery of taxolNadja B Cech, Nicholas H OberliesExpert Opinion on Drug Metabolism & Toxicology|February 3, 2007
Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactionsMary F Paine, Nicholas H OberliesJournal of Natural Products|February 28, 2004
Camptothecin and taxol: historic achievements in natural products researchNicholas H Oberlies, David J KrollJournal of Natural Products|October 20, 2025
Machine-Readable Structural Information Is Essential for Natural Products ResearchKarin Steffen, Nicholas H Oberlies, Antonis RokasPharmacology & Therapeutics|August 14, 2012
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transportChristina S Won, Nicholas H Oberlies, Mary F PaineCurrent Drug Metabolism|December 30, 2010
Influence of dietary substances on intestinal drug metabolism and transportChristina S Won, Nicholas H Oberlies, Mary F PaineJournal of Natural Products|April 5, 2011
Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metaboliteCherilyn R Strader, Cedric J Pearce, Nicholas H OberliesIntegrative Cancer Therapies|June 6, 2007
Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studiesDavid J Kroll, Heather S Shaw, Nicholas H OberliesCarcinogenesis|March 29, 2007
Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cellsGagan Deep, Nicholas H Oberlies, David J Kroll, et al.Pageof 26